VeriMomsodium c12-13 pareth-5 carboxylate est-il sûr pendant la grossesse ?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive hazard statements were found for this ingredient; no peer‑reviewed evidence of reproductive toxicity or endocrine activity was identified in regulatory summaries (PubChem/ECHA/CosIng). As an anionic ethoxylated fatty alcohol carboxylate surfactant, systemic absorption from typical topical cosmetic use is low but measurable, so exposure is assigned as low (e=1). Sources: ECHA registration/CosIng/PubChem; absence of ECHA Annex VI harmonised classification and no CIR/SCCS repro findings.
Related ingredients
Frequently asked questions
- sodium c12-13 pareth-5 carboxylate est-il sûr pendant la grossesse ?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive hazard statements were found for this ingredient; no peer‑reviewed evidence of reproductive toxicity or endocrine activity was identified in regulatory summaries (PubChem/ECHA/CosIng). As an anionic ethoxylated fatty alcohol carboxylate surfactant, systemic absorption from typical topical cosmetic use is low but measurable, so exposure is assigned as low (e=1). Sources: ECHA registration/CosIng/PubChem; absence of ECHA Annex VI harmonised classification and no CIR/SCCS repro findings.
- sodium c12-13 pareth-5 carboxylate est-il sûr pendant l'allaitement ?
- Same rationale as pregnancy: no evidence of reproductive or lactation-specific toxicity in regulatory databases or safety assessments. Dermal use leads to low but measurable systemic exposure in adults, so breastfeeding exposure is scored low (e=1).
- sodium c12-13 pareth-5 carboxylate est-il sûr pour la peau de bébé ?
- No infant-specific reproductive or developmental toxicity evidence was found. Because infant skin has higher permeability, exposure score is increased by +1 relative to adult (adult e=1 → infant e=2). No data indicating direct dermal developmental hazard in 0–3 yr olds were identified in CIR/SCCS/ECHA summaries.
- Comment VeriMom évalue-t-il sodium c12-13 pareth-5 carboxylate ?
- VeriMom évalue sodium c12-13 pareth-5 carboxylate à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à sodium c12-13 pareth-5 carboxylate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à sodium c12-13 pareth-5 carboxylate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.